During the JPMorgan Healthcare Conference in San Francisco, NVIDIA presented its most recent developments in ...

Nvidia (NASDAQ: NVDA) was a $360 billion company at the start of 2023, but just two years later, its worth has accelerated to ...

A Minneapolis-based med-tech software firm that's been backed by Nvidia Corp., Novalis Lifesciences and Microsoft recently ...

AI development powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference in San Francisco by announcing new ...

J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers ...

The 18-year-old was among the winners of NeurIPS’s first research competition for high schoolers. He was thrilled to be among ...

The global clinical informatics market, valued at US$ 198.33 Billion in 2023, is forecasted to grow at a robust CAGR of 16.0%, reaching US$ ...

Nvidia has been doubling down on the opportunity to build robotics and other industrial AI applications, with the launch of ...

Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions.

J.P. Morgan analyst Harlan Sur has maintained their bullish stance on NVDA stock, giving a Buy rating yesterday.Stay Ahead of the ...

The latest edition of STAT’s Health Tech newsletter brings you important dispatches from the J.P. Morgan Health Care ...

Mayo Clinic has partnered with Aignostics and Nvidia ... AI solutions for advanced diagnosis and care of patients, and that ...